Post by Takeda

1,721,882 followers

Tyrosine kinase 2 (TYK2) is primarily involved in immune-specific signaling, while the Janus kinase (JAK) enzymes regulate broader biological processes. Targeting TYK2 has become an area of interest for immune-mediated inflammatory diseases, like #psoriasis and #PsoriaticArthritis, in efforts to potentially mitigate effects on other JAK-mediated processes. Explore TYK2 with Salome Juethner, US Medical Head of Dermatology & Rheumatology at Takeda.

Post content

Video Content